A Market Shaping Approach for the Biopharmaceutical Industry: Governing Innovation Towards the Public Interest

Mariana Mazzucato · Henry Lishi Li

60 citations0/0 files storedThe Journal of Law Medicine & Ethics

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Biomedical Ethics and Regulation Biotechnology and Related Fields

Abstract

Enhancing research and development and ensuring equitable pricing and access to cutting-edge treatments are both vital to a biopharmaceutical innovation system that works in the public interest. However, despite delivering numerous therapeutic advances, the existing system suffers from major problems: a lack of directionality to meet key needs, inefficient collaboration, high prices that fail to reflect the public contribution, and an overly-financialized business model.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 60 citations exist upstream.

References

1983An Evolutionary Theory of Economic Change.1981Credit Rationing in Markets with Imperfect Information 2007The Economics of Climate Change: The Stern Review 2007The Economics of Climate Change 2014The entrepreneurial state: debunking public vs. private sector myths 1972Economic Welfare and the Allocation of Resources for Invention 2013Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?2020Industrial Policy in the 21st Century

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.